Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Human Molecular Genetics

• Publication date

  2006-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/HMG/DDL030PMID 16500997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lewy bodies.

  2006cited by this paper
• Multiple regions of α‐synuclein are associated with Parkinson's disease

  2005cited by this paper
• Causal relation between α synuclein gene duplication and familial Parkinson’s disease

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies

  2005cited by this paper
• Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

  2005influential reference
• Alpha-synuclein locus duplication as a cause of familial Parkinson's disease.

  2004cited by this paper
• Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology.

  2004cited by this paper
• Causal relation between α-synuclein locus duplication as a cause of familial Parkinson's disease

  2004cited by this paper
• Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease.

  2004cited by this paper
• alpha-Synuclein promoter confers susceptibility to Parkinson's disease.

  2004cited by this paper
• α-Synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication

  2004cited by this paper
• α-synuclein locus duplication as a cause of familial Parkinson's disease

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• α‐Synuclein promoter confers susceptibility to Parkinson's disease

  2004cited by this paper
• Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.

  2004cited by this paper
• Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

  2004cited by this paper
• Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease.

  2004cited by this paper
• Limitations of current Parkinson's disease therapy

  2003influential reference
• Role of α-Synuclein Carboxy-Terminus on Fibril Formation in Vitro†

  2003cited by this paper
• Genetic and environmental factors in the cause of Parkinson's disease

  2003influential reference
• Role of alpha-synuclein carboxy-terminus on fibril formation in vitro.

  2003cited by this paper
• Mutations in NR4A2 associated with familial Parkinson disease

  2003cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• Caught in the act: alpha-synuclein is the culprit in Parkinson's disease.

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• Alpha synuclein promoter and risk of Parkinson's disease: microsatellite and allelic size variability.

  2003cited by this paper
• A haplotype map of the human genome.

  2003cited by this paper
• A haplotype map of the human genome

  2003cited by this paper
• Genome screen to identify susceptibility genes for Parkinson disease in a sample without parkin mutations.

  2002cited by this paper
• A susceptibility gene for late‐onset idiopathic Parkinson's disease

  2002cited by this paper
• Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190 562 genetic variations in the human genome

  2002cited by this paper
• Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism

  2002cited by this paper
• Complete genomic screen in Parkinson disease: evidence for multiple genes.

  2001cited by this paper
• alpha-Synuclein gene haplotypes are associated with Parkinson's disease.

  2001cited by this paper
• Genome-wide scan for Parkinson's disease: the GenePD Study.

  2001cited by this paper
• Familial aggregation of Parkinson's disease.

  2001influential reference
• Mutations in the alpha-synuclein gene in Parkinson's disease among Indians.

  2001cited by this paper
• Genome-wide scan for Parkinson’s disease:: The Gene PD Study

  2001cited by this paper
• α-synuclein gene haplotypes are associated with Parkinson’s disease

  2001cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001cited by this paper
• Mutations in the α‐synuclein gene in Parkinson's disease among Indians

  2001cited by this paper
• Genome-wide scan for Parkinson's disease

  2001cited by this paper
• Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease.

  2001cited by this paper
• Familial aggregation of Parkinson's disease in Iceland.

  2000cited by this paper
• Fiber diffraction of synthetic a-synuclein filaments shows amyloid-like cross-b conformation

  2000cited by this paper
• Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.

  2000cited by this paper
• Familial aggregation of Parkinson’s disease

  1999cited by this paper
• Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990

  1999cited by this paper
• The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins

  1999cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• The ubiquitin pathway in Parkinson's disease

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Mutation, sequence analysis, and association studies of α-synuclein in Parkinson's disease

  1998cited by this paper
• Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• Genetic studies in Alzheimer's disease with an NACP/α‐synuclein polymorphism

  1996influential reference
• Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism.

  1996cited by this paper
• Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

  1988cited by this paper

• ZSCAN21 mediates the pathogenic transcriptional induction of α-synuclein in cellular and animal models of Parkinson’s disease

  2025cites this paper
• Trends and challenges of AAV-delivered gene editing therapeutics for CNS disorders: Implications for neurodegenerative disease

  2025cites this paper
• A fragment of Calpain-1 cleaved α-Synuclein quantified in serum is upregulated in patients with Parkinson’s disease

  2025cites this paper
• SNCA-targeted epigenome therapy for Parkinson’s disease alleviates pathological and behavioral perturbations in a mouse model

  2025cites this paper
• Meta-analysis and in-silico functional characterization of the SNCA variant rs356220 in Parkinson’s disease

  2025cites this paper
• Parkinson disease is a fatty acidopathy

  2025cites this paper
• SARS-CoV-2 infection causes dopaminergic neuron senescence

  2024influential citation
• Genes to therapy: a comprehensive literature review of whole-exome sequencing in neurology and neurosurgery

  2024cites this paper
• α-Synuclein Attenuates Maneb Neurotoxicity through the Modulation of Redox-Sensitive Transcription Factors

  2023cites this paper
• Neuronal-type-specific epigenome editing to decrease SNCA expression: Implications for precision medicine in synucleinopathies

  2023cites this paper
• Gene Co-expression Analysis of the Human Substantia Nigra Identifies ZNHIT1 as an SNCA Co-expressed Gene that Protects Against α-Synuclein-Induced Impairments in Neurite Growth and Mitochondrial Dysfunction in SH-SY5Y Cells

  2022cites this paper
• Longitudinal Study of SNCA Rep1 Polymorphism on Executive Function in Early Parkinson’s Disease

  2022cites this paper
• Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy

  2022cites this paper
• miRNA in Parkinson's disease: From pathogenesis to theranostic approaches

  2022cites this paper
• Cell-Type Specific Changes in DNA Methylation of SNCA Intron 1 in Synucleinopathy Brains

  2021cites this paper
• Alpha synuclein (SNCA) rs7684318 variant contributes to Parkinson's disease risk by altering transcription factor binding related with Notch and Wnt signaling.

  2021cites this paper
• Cyclophilin D binds to the acidic C-terminus region of α-Synuclein and affects its aggregation characteristics

  2020cites this paper
• miR‐30b protects nigrostriatal dopaminergic neurons from MPP(+)‐induced neurotoxicity via SNCA

  2020cites this paper
• Interaction between SNCA gene polymorphisms and T2DM with Parkinson’s disease

  2020cites this paper
• Pathways of protein synthesis and degradation in PD pathogenesis.

  2020cites this paper
• The SNCA-Rep1 Polymorphic Locus: Association with the Risk of Parkinson’s Disease and SNCA Gene Methylation

  2020cites this paper
• Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease

  2020cites this paper
• The Role of Genetics in Alzheimer's Disease and Parkinson's Disease

  2019cites this paper
• Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation.

  2019cites this paper
• Modeling α-Synuclein Propagation with Preformed Fibril Injections

  2019cites this paper
• Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson’s disease

  2019cites this paper
• Age-related diseases as vicious cycles.

  2019cites this paper
• Motor Functioning and Parkinson’s Disease: Insights from the general population

  2019cites this paper
• Creatine Supplement Effect Similar in Rotenone Induced and Transgenic PD Flies in Drosophila Melanogaster

  2019cites this paper
• SNCA Rep1 promoter variability influences cognition in Parkinson's disease

  2019cites this paper
• Biomarkers of Parkinson's Disease

  2019cites this paper
• Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's disease.

  2018cites this paper
• 2 Genetics of Parkinson Disease

  2018cites this paper
• The Use of Co-immunoprecipitation to Study Conformation-Specific Protein Interactions of Oligomeric α-Synuclein Aggregates

  2018cites this paper
• Alpha‐synuclein mRNA isoform formation and translation affected by polymorphism in the human SNCA 3ʹUTR

  2018cites this paper
• Disorders with Synuclein Pathology and P arkinsonism

  2018cites this paper
• A Comprehensive Analysis of the Association Between SNCA Polymorphisms and the Risk of Parkinson's Disease

  2018cites this paper
• Advancing Stem Cell Models of Alpha-Synuclein Gene Regulation in Neurodegenerative Disease

  2018cites this paper
• Some genetic factors of Parkinson’s disease in the Hungarian population

  2018cites this paper
• Alterations of NURR1 and Cytokines in the Peripheral Blood Mononuclear Cells: Combined Biomarkers for Parkinson’s Disease

  2018cites this paper
• Genetic analysis of α‐synuclein 3′ untranslated region and its corresponding microRNAs in relation to Parkinson's disease compared to dementia with Lewy bodies

  2017cites this paper
• Interpreting Gene Expression Effects of Disease-Associated Variants: A Lesson from SNCA rs356168

  2017cites this paper
• Structural variants in SNCA gene and the implication to synucleinopathies.

  2017cites this paper
• Genetic analysis of SNCA gene polymorphisms in Parkinson’s disease in an Iranian population

  2017cites this paper
• SNCA 3′UTR genetic variants in patients with Parkinson’s disease and REM sleep behavior disorder

  2017cites this paper
• Haplotype analysis of the IGF 2-INS-TH gene cluster in Parkinson ’ s disease

  2017cites this paper
• The BSSG rat model of Parkinson’s disease: progressing towards a valid, predictive model of disease

  2017cites this paper
• NR4A2 genetic variation and Parkinson's disease: Evidence from a systematic review and meta-analysis.

  2017influential citation
• Parkinsonism and Related Disorders

  2016cites this paper
• Up-regulation of SNCA gene expression: implications to synucleinopathies

  2016cites this paper
• Analysis of LRRK 2 , SNCA , and ITGA 8 Gene Variants with Sporadic Parkinson ’ s Disease Susceptibility in Chinese Han Population

  2016cites this paper
• The rs3756063 polymorphism is associated with SNCA methylation in the Chinese Han population.

  2016cites this paper
• Synaptic failure and α‐synuclein

  2016cites this paper
• Potential Role of Epigenetic Mechanism in Manganese Induced Neurotoxicity

  2016cites this paper
• The genetic background of Parkinson's disease: current progress and future prospects

  2016cites this paper
• Genetic Variants in MicroRNAs and Their Binding Sites Are Associated with the Risk of Parkinson Disease

  2016cites this paper
• Association of Parkinson’s Disease GWAS-Linked Loci with Alzheimer’s Disease in Han Chinese

  2016cites this paper
• SNCA rs356182 variant increases risk of sporadic Parkinson's disease in ethnic Chinese.

  2016cites this paper
• Analysis of LRRK2, SNCA, and ITGA8 Gene Variants with Sporadic Parkinson's Disease Susceptibility in Chinese Han Population

  2016cites this paper
• Genetic association of NOS1 exon18, NOS1 exon29, ABCB1 1236C/T, and ABCB1 3435C/T polymorphisms with the risk of Parkinson's disease

  2016cites this paper
• [Frequency of single nucleotide polymorphisms and alpha-synuclein haplotypes associated with sporadic Parkinson's disease in the Mexican population].

  2016cites this paper
• An update on the rotenone models of Parkinson's disease: their ability to reproduce the features of clinical disease and model gene-environment interactions.

  2015cites this paper
• A cytosine‐thymine (CT)‐rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression

  2015cites this paper
• Βιοπληροφορική ανάλυση του νευρικού συστήματος

  2015cites this paper
• Study of the transcriptional regulation of α-synuclein

  2015cites this paper
• Association between ubiquitin carboxy-terminal hydrolase-L1 S18Y variant and risk of Parkinson’s disease: the impact of ethnicity and onset age

  2015cites this paper
• SNCA Gene, but Not MAPT, Influences Onset Age of Parkinson's Disease in Chinese and Australians

  2015cites this paper
• Alpha‐synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta‐analysis

  2015cites this paper
• Genetic variability in ABCB1, occupational pesticide exposure, and Parkinson's disease.

  2015cites this paper
• Polymorphism in the Vesicular Monoamine Transporter 2 Gene Decreases the Risk of Parkinson's Disease in Han Chinese Men

  2015cites this paper
• Comparative analysis of four disease prediction models of Parkinson’s disease

  2015cites this paper
• Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity

  2015cites this paper
• Normalization of Overexpressed α-Synuclein Causing Parkinson's Disease By a Moderate Gene Silencing With RNA Interference.

  2015cites this paper
• Identification of parkin interactions: implications for Parkinson’s disease

  2015cites this paper
• Discovery of functional non-coding conserved regions in the α-synuclein gene locus

  2014cites this paper
• COMT gene and risk for Parkinson’s disease: a systematic review and meta-analysis

  2014cites this paper
• Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study

  2014cites this paper
• Lack of association between UCHL1 S18Y gene polymorphism and Parkinson’s disease in the Asian population: a meta-analysis

  2014cites this paper
• UCH-L1 S18Y Variant and Risk of Parkinson's Disease in Asian Populations: An Updated Meta-Analysis

  2014cites this paper
• Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

  2014influential citation
• The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

  2014cites this paper
• α-Synuclein Transgenic Drosophila As aModel of Parkinson ’ s Disease and Related

  2014cites this paper
• Discovery of functional non-coding conserved regions in the α-synuclein gene locus.

  2014cites this paper
• Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson's disease: A meta-analysis.

  2014cites this paper
• The genetic contributions of SNCA and LRRK2 genes to Lewy Body pathology in Alzheimer's disease.

  2014cites this paper
• Splice isoform and pharmacological studies reveal that sterol depletion relocalizes α-synuclein and enhances its toxicity

  2014cites this paper
• Genetic variants and animal models in SNCA and Parkinson disease.

  2014cites this paper
• SNCA rs356219 variant increases risk of sporadic Parkinson's disease in ethnic Chinese

  2013influential citation
• [The role of extracellular α-synuclein in molecular mechanisms of cell death].

  2013cites this paper
• Specific pesticide-dependent increases in α-synuclein levels in human neuroblastoma (SH-SY5Y) and melanoma (SK-MEL-2) cell lines.

  2013cites this paper
• Genetic susceptibility loci, environmental exposures, and Parkinson's disease: a case-control study of gene-environment interactions.

  2013cites this paper
• α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease

  2013cites this paper
• YY1 binds to α-synuclein 3′-flanking region SNP and stimulates antisense noncoding RNA expression

  2013cites this paper
• PITX3 and Risk for Parkinson's Disease: A Systematic Review and Meta-Analysis

  2013cites this paper
• Modeling Disease-Related Proteins in Saccharomyces cerevisiae: Insights into Alpha-Synuclein and TorsinA Biology

  2013cites this paper
• Genetic variants of SNCA and LRRK2 genes are associated with sporadic PD susceptibility: a replication study in a Taiwanese cohort.

  2013cites this paper
• Association of vitamin D receptor gene polymorphisms and Parkinson's disease in Hungarians.

  2013cites this paper
• Polymorphisms in the SNCA Gene: Association with the Risk of Development of the Sporadic Form of Parkinson’s Disease and the Level of SNCA Gene Expression in Peripheral Blood of Patients from Russia

  2013cites this paper
• Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease

  2013cites this paper
• THE PROTECTIVE ROLE OF NRF2/KEAP1 IN NEUROLOGICAL DISEASE AND OXIDATIVE STRESS-INDUCED CELL DAMAGE

  2013cites this paper